Old Web
English
Sign In
Acemap
>
authorDetail
>
Tommaso Muto
Tommaso Muto
Medicine
Pharmacogenomics
Cancer
Genotyping
Pharmacology
5
Papers
41
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant Detection.
2020
Raffaele Di Francia
Stefania Crisci
Tommaso Muto
Concetta Giancola
Luigi Petriccone
Oriana Catapano
Annunziata Cummarro
Antonio Pinto
Ferdinando Frigeri
Show All
Source
Cite
Save
Citations (1)
Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
2019
Medicina-buenos Aires
Stefania Crisci
Filomena Amitrano
Mariangela Saggese
Tommaso Muto
Sabrina Sarno
Sara Mele
Pasquale Vitale
Giuseppina Ronga
Massimiliano Berretta
Raffaele Di Francia
Show All
Source
Cite
Save
Citations (10)
Evaluation of genotyping methods and costs for MTHFR, CBS and MTRR polymorphisms in patients with vitiligo.
2019
European Review for Medical and Pharmacological Sciences
S. Di Martino
Tommaso Muto
V. de Lucia
Show All
Source
Cite
Save
Citations (0)
Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
2017
Frontiers in Pharmacology
Raffaele Di Francia
Luigi Atripaldi
Salvo Di Martino
Carla Fierro
Tommaso Muto
Anna Crispo
Sabrina Rossetti
Gaetano Facchini
Massimiliano Berretta
Show All
Source
Cite
Save
Citations (3)
Drug–Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection
2016
Frontiers in Pharmacology
Massimiliano Berretta
Michele Caraglia
Ferdinando Martellotta
Silvia Zappavigna
Angela Lombardi
Carla Fierro
Luigi Atripaldi
Tommaso Muto
Daniela Valente
Paolo De Paoli
Umberto Tirelli
Raffaele Di Francia
Show All
Source
Cite
Save
Citations (27)
1